Business Description
Organovo Holdings Inc
NAICS : 541714
SIC : 2836
ISIN : US68620A1043
Description
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.82 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -53.44 | |||||
| Beneish M-Score | -4.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 12.7 | |||||
| 3-Year EPS without NRI Growth Rate | 13.1 | |||||
| 3-Year FCF Growth Rate | 6.9 | |||||
| 3-Year Book Growth Rate | -57.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 17.44 | |||||
| Future 3-5Y Total Revenue Growth Rate | 27.55 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.75 | |||||
| 9-Day RSI | 37.33 | |||||
| 14-Day RSI | 37.24 | |||||
| 6-1 Month Momentum % | -47.61 | |||||
| 12-1 Month Momentum % | -57.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.58 | |||||
| Quick Ratio | 3.38 | |||||
| Cash Ratio | 3.04 | |||||
| Days Inventory | 64331.25 | |||||
| Days Sales Outstanding | 318 | |||||
| Days Payable | 114610 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.1 | |||||
| Shareholder Yield % | -85.04 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 97.26 | |||||
| Operating Margin % | -19557.53 | |||||
| Net Margin % | -19160.27 | |||||
| FCF Margin % | -16920.55 | |||||
| ROE % | -190.68 | |||||
| ROA % | -138.17 | |||||
| ROIC % | -415.06 | |||||
| ROC (Joel Greenblatt) % | -668.77 | |||||
| ROCE % | -171.38 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 63.86 | |||||
| PB Ratio | 0.96 | |||||
| Price-to-Tangible-Book | 0.96 | |||||
| EV-to-EBIT | -0.14 | |||||
| EV-to-EBITDA | -0.14 | |||||
| EV-to-Revenue | 26.95 | |||||
| EV-to-Forward-Revenue | 9.78 | |||||
| EV-to-FCF | -0.16 | |||||
| Price-to-Net-Current-Asset-Value | 1.44 | |||||
| Price-to-Net-Cash | 1.87 | |||||
| Earnings Yield (Greenblatt) % | -714.29 | |||||
| FCF Yield % | -179.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Organovo Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.073 | ||
| EPS (TTM) ($) | -1.38 | ||
| Beta | 2.3 | ||
| Volatility % | 36.6 | ||
| 14-Day RSI | 37.24 | ||
| 14-Day ATR ($) | 0.014893 | ||
| 20-Day SMA ($) | 0.483995 | ||
| 12-1 Month Momentum % | -57.11 | ||
| 52-Week Range ($) | 0.45 - 2.038 | ||
| Shares Outstanding (Mil) | 15.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Organovo Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Organovo Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Organovo Holdings Inc Frequently Asked Questions
What is Organovo Holdings Inc(LTS:0R02)'s stock price today?
The current price of LTS:0R02 is $0.45. The 52 week high of LTS:0R02 is $2.04 and 52 week low is $0.45.
When is next earnings date of Organovo Holdings Inc(LTS:0R02)?
The next earnings date of Organovo Holdings Inc(LTS:0R02) is 2024-11-08 Est..
Does Organovo Holdings Inc(LTS:0R02) pay dividends? If so, how much?
Organovo Holdings Inc(LTS:0R02) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers